134 filings
Page 4 of 7
6-K
ap1oigcedm4y40ayrhh
25 Jul 22
Legend Biotech Corporation Announces Proposed Public Offering
4:07pm
6-K
69jxl kyymqj
21 Jul 22
Legend Biotech Corporation 6-K
6:00am
6-K
uhw9l4n0qmvl8fr97ug
13 Jul 22
Amendment No. 1 to Interim Product Supply Agreement
8:30am
6-K
k92 d8gaogy
7 Jul 22
Legend Biotech Corporation Form 6-K
8:31am
6-K
80m15w7afrc3ngidm27
6 Jun 22
Legend Biotech Corporation Form 6-K
6:00am
6-K
14jg08hmy1pk3za bym
3 Jun 22
Legend Biotech Corp. 6-K
8:30am
6-K
quw7uobi6
2 Jun 22
Legend Biotech Corp. 6-K
3:24pm
6-K
59kp1haz66 if7tuavf
1 Jun 22
Legend Biotech Corporation 6-K
8:30am
6-K
7jf41iauwrlxt1eh
26 May 22
Legend Biotech Corp. 6-K
6:02am
6-K
vlv9d3h pumidivhs
18 May 22
Legend Biotech Corp. 6-K
8:30am
6-K
w3ck 6fkgnabhph
9 May 22
Legend Biotech Corporation 6-K
6:32am
6-K
fkwp4htnt72rvvhz
9 May 22
Legend Biotech Corporation 6-K
6:30am
6-K
n2rnkr4j2nxa1f
6 May 22
Legend Biotech Corporation 6-K
4:02pm
6-K
d6iaubyl3kg5 2q5s56p
21 Apr 22
Legend Biotech Corporation 6-K
8:33am
6-K
3sl zzbczia
13 Apr 22
Legend Biotech Corporation Form 6-K
5:30pm
6-K
rhapzi
1 Apr 22
Legend Biotech Corp. 6-K
4:01pm
6-K
s3bxb qih93g8eqjt19
25 Mar 22
Ciltacabtagene autoleucel, if approved by the European Commission (EC), will be Legend Biotech’s first EC-approved product
8:14am
6-K
dzg4coacywrq3cqwf
18 Mar 22
Legend Biotech Corporation 6-K
4:10pm
6-K
j7jwo952
7 Mar 22
Legend Biotech Corp. 6-K
6:03am
6-K
vzbx ebhkv71
1 Mar 22
Legend Biotech Corp. 6-K
6:00am